LINCOLN PHARMACEUTICALS LTD. - 531633 - Intimation Of Book Closure
Annual Report for the Financial Year 2019 - 2020 of the Company.05-09-2020
05-09-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Notice Of 26Th Annual General Meeting Of The Company.
Notice of the 26th Annual General Meeting of the members of the Company will be held on Wednesday, September 30, 2020 at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM").05-09-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendra Gulabdas Patel with PACs28-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclosed herewith the copies of published newspaper advertisement with respect to compliance with Circular No. 20/2020 dated May 5, 2020 issued by Ministry of Corporate Affairs, with respect to 26th Annual General Meeting of the Company scheduled to be held on Wednesday, September 30, 2020 at 11:00 a.m. through Video Conferencing / Other Audio Visual Means.28-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copies of published newspaper advertisement with respect to the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter Ended June 30, 2020.21-08-2020
Lincoln Pharma Q1 standalone net rises 25% to 15 crore
Lincoln Pharmaceuticals Limited on Thursday posted standalone net profit of 15 crore for the first quarter ended June 2020, as against 12 crore in20-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2020.
we would like to inform that the Board of Directors of the Company at their meeting held today i.e. Thursday, August 20, 2020, have considered and approved the Un-Audited Financial Results of the Company (Standalone and Consolidated) along with the limited review report for the Quarter Ended on June 30, 2020. We also enclose herewith Financial Highlights of the Company for the aforesaid quarter.20-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Outcome Of The Board Meeting
we would like to inform that the Board of Directors of the Company at their meeting held today i.e. Thursday, August 20, 2020, have considered and approved the Un-Audited Financial Results of the Company (Standalone and Consolidated) along with the limited review report for the Quarter Ended on June 30, 2020. We also enclose herewith Financial Highlights of the Company for the aforesaid quarter.20-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On June 30, 2020 Along With Any Other Business, If Any.
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2020 along with any other business, if any.13-08-2020
LINCOLN PHARMACEUTICALS LTD. - 531633 - Newspaper Advertisement For Transfer Of Equity Shares To Investor Education Protection Fund Authority CIEPF Authority).
With reference to the above captioned subject matter, pursuant to the provisions of section 124 (6) of the Companies Act, 2013 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of notice published in the newspaper on August 03, 2020 as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof, inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends for last seven consecutive years, failing which their shares would be transferred to IEPF Authority.04-08-2020